164 related articles for article (PubMed ID: 30063722)
21. Amino acids at positions 3, 168, and 169 are associated with the ability of Nef proteins from HIV-1 CRF01_AE to downmodulate CD4.
Kuang WD; Zhou YH; Zhong P; Zhang C; Wang JH
J Med Virol; 2017 Oct; 89(10):1788-1795. PubMed ID: 28500742
[TBL] [Abstract][Full Text] [Related]
22. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
[TBL] [Abstract][Full Text] [Related]
23. Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals.
Li K; Chen H; Li J; Feng Y; Lan G; Liang S; Liu M; Rashid A; Xing H; Shen Z; Shao Y
Emerg Microbes Infect; 2022 Dec; 11(1):158-167. PubMed ID: 34895083
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Subtype Shift in the Philippines is Associated With High Transmitted Drug Resistance, High Viral Loads, and Fast Immunologic Decline.
Salvaña EMT; Dungca NT; Arevalo G; Li K; Francisco C; Penalosa C; Dela Tonga A; Leyritana K; Solante R; Tactacan-Abrenica RJ; Lim J; Alejandria M; Palaypayon N; Schwem B
Int J Infect Dis; 2022 Sep; 122():936-943. PubMed ID: 35788414
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.
Zhang H; He C; Jiang F; Cao S; Zhao B; Ding H; Dong T; Han X; Shang H
BMC Immunol; 2022 Apr; 23(1):15. PubMed ID: 35366796
[TBL] [Abstract][Full Text] [Related]
28. Disparate impact on CD4 T cell count by two distinct HIV-1 phylogenetic clusters from the same clade.
Song H; Ou W; Feng Y; Zhang J; Li F; Hu J; Peng H; Xing H; Ma L; Tan Q; Li D; Wang L; Wu B; Shao Y
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):239-244. PubMed ID: 30559208
[TBL] [Abstract][Full Text] [Related]
29. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.
Kivelä PS; Krol A; Salminen MO; Geskus RB; Suni JI; Anttila VJ; Liitsola K; Zetterberg V; Miedema F; Berkhout B; Coutinho RA; Ristola MA
Scand J Infect Dis; 2005; 37(4):276-83. PubMed ID: 15871166
[TBL] [Abstract][Full Text] [Related]
30. HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.
Arroyo MA; Phanuphak N; Krasaesub S; Sirivichayakul S; Assawadarachai V; Poltavee K; Pankam T; Ananworanich J; Paris R; Tovanabutra S; Kijak GH; McCutchan FE; Phanuphak P; Kim JH; de Souza M
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):5-12. PubMed ID: 20055593
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.
Kiwanuka N; Robb M; Laeyendecker O; Kigozi G; Wabwire-Mangen F; Makumbi FE; Nalugoda F; Kagaayi J; Eller M; Eller LA; Serwadda D; Sewankambo NK; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Whalen CC
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):180-4. PubMed ID: 20010433
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival.
Costello C; Nelson KE; Suriyanon V; Sennun S; Tovanabutra S; Heilig CM; Shiboski S; Jamieson DJ; Robison V; Rungruenthanakit K; Duerr A
Int J Epidemiol; 2005 Jun; 34(3):577-84. PubMed ID: 15737969
[TBL] [Abstract][Full Text] [Related]
33. Dual Infection Contributes to Rapid Disease Progression in Men Who Have Sex With Men in China.
Luan H; Han X; Yu X; An M; Zhang H; Zhao B; Xu J; Chu Z; Shang H
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):480-487. PubMed ID: 28490044
[TBL] [Abstract][Full Text] [Related]
34. Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors.
Rutvisuttinunt W; Sirivichayakul S; Oota S; Assawadarachai V; Poltavee K; Savadsuk H; Pattanachaiwit S; Chaemchuen S; Arroyo MA; Paris RM; Michael NL; Kim JH; Ruxrungtham K; de Souza M; Phanuphak P; Tovanabutra S
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1703-11. PubMed ID: 22587412
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.
Kantor R; Smeaton L; Vardhanabhuti S; Hudelson SE; Wallis CL; Tripathy S; Morgado MG; Saravanan S; Balakrishnan P; Reitsma M; Hart S; Mellors JW; Halvas E; Grinsztejn B; Hosseinipour MC; Kumwenda J; La Rosa A; Lalloo UG; Lama JR; Rassool M; Santos BR; Supparatpinyo K; Hakim J; Flanigan T; Kumarasamy N; Campbell TB; Eshleman SH;
Clin Infect Dis; 2015 May; 60(10):1541-9. PubMed ID: 25681380
[TBL] [Abstract][Full Text] [Related]
37. A Novel HIV-1 CRF01_AE/B recombinant among men who have sex with men in Jiangsu Province, China.
Guo H; Hu H; Zhou Y; Yang H; Huan X; Qiu T; Fu G; Ding P
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):706-10. PubMed ID: 24601765
[TBL] [Abstract][Full Text] [Related]
38. [Characteristic and dynamic of HIV-1 subtype distribution in men who have sex with men in Guangzhou, 2008-2015].
Han ZG; Zhang YL; Wu H; Cheng WB; Liang CY; Zhong F; Gao K; Xu HF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):67-71. PubMed ID: 29374899
[No Abstract] [Full Text] [Related]
39. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.
Ssemwanga D; Nsubuga RN; Mayanja BN; Lyagoba F; Magambo B; Yirrell D; Van der Paal L; Grosskurth H; Kaleebu P
PLoS One; 2013; 8(8):e71768. PubMed ID: 23951241
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
